We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA approves expansion of Avzivi biosimilar production to 4000 L. Learn how this will lower bevacizumab prices and reshape the market. Detailed analysis.
